PATENT CLAIM ANALYSIS

Application Number: 16002364
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["424", "137100"]

Abstract:
The invention generally relates to antibodies that bind to human folate receptor and diagnostic assays for folate receptor 1-based therapies. Methods of using the antibodies to monitor therapy are further provided.

Claim (Index 25):
A method of detecting FOLR1 expression in a sample comprising contacting said sample with an antibody, antigen-binding fragment thereof, or polypeptide that specifically binds to the same FOLR1 epitope as an antibody selected from the group consisting of:\n (a) an antibody comprising the polypeptide of SEQ ID NO:27 and the polypeptide of SEQ ID NO:28; (b) an antibody comprising the polypeptide of SEQ ID NO:29 and the polypeptide of SEQ ID NO:30; (c) an antibody comprising the polypeptide of SEQ ID NO:31 and the polypeptide of SEQ ID NO:32; (d) an antibody comprising the polypeptide of SEQ ID NO:62 and the polypeptide of SEQ ID NO:63 or SEQ ID NO:64; and (e) an antibody comprising the polypeptide of SEQ ID NO:65 and the polypeptide of SEQ ID NO:66 or SEQ ID NO:67.

Metadata:
- Claim Count in Document: 86.0
- Percentile: 94.0
- Lexical Diversity: 1.22222
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15473008', '14473828', '14921596', '15620117', '14015653']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7673563098957651
- 35 USC 102 Novelty (BERT): 0.6608649578578284
- Combined Prediction Score: 0.7567071746919715
- Mean Citation Score: 555.782786
- Max Citation Score: 684.2430400000002
- Similarity Product: 606.0820547569563

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test